Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC ECs

This article was originally published in The Tan Sheet

Executive Summary

Safety and regulatory appropriateness of emergency contraceptives available without a prescription stressed by David Grimes, MD, Family Health International, et al., in July issue of Obstetrics & Gynecology. Authors discuss medical and legal implications of issue, arguing "unintended pregnancies remain endemic in the United States, and wider use of emergency contraceptive pills could substantially help." Family Health International has been helping to design label comprehension and actual use studies to support a switch NDA for Women's Capital Corporation's Plan B (1"The Tan Sheet" Dec. 18, 2000, p. 3)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092767

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel